Key facts
| Recalling firm | OPTIMAL BALANCE PHARMACY |
|---|---|
| Manufacturer | Not disclosed in the FDA record. |
| Brand name | Not disclosed in the FDA record. |
| Product description | Glutathione 200 mg/mL, 30 mL sterile multidose vial, Each vial contains: Glutathione, Ascorbic Acid, Benzyl Alcohol & sterile water for injection, For IM or IV Injection Use Only, RX only, Optimal Balance Pharmacy, 2204 Cypress Creek Pkwy Suite F, Houston, TX 77090 |
| Classification | Class I |
| Recall number | D-0851-2026 |
| Report date | Not disclosed in the FDA record. |
| Status | Ongoing |
| Reason for recall | Microbial Contamination of Sterile Products - out of specifications results were obtained for bacterial endotoxin. |
What this classification means
A Class I recall is FDA’s most serious classification. FDA assigns Class I when there is a reasonable probability that use of, or exposure to, the recalled product will cause serious adverse health consequences or death. This classification does not mean harm has already occurred in every case -- it reflects FDA’s assessment of the realistic worst-case risk profile of the defect described in the recall, based on the reason for recall reported by the firm. Class I recalls receive the closest FDA monitoring of the three classes: the recalling firm typically must submit a recall strategy, periodic status reports, and effectiveness checks confirming that the affected lots have actually been removed from distribution or corrected in the field. FDA's Center for Devices and Radiological Health (for devices) or Center for Drug Evaluation and Research (for drugs) reviews the classification and can require additional corrective action if the initial response is judged insufficient. Because this record is filed as Class I, professionals and consumers handling an affected lot should treat FDA's own classification -- not this page's summary of it -- as the authoritative risk signal. A Class I recall is FDA’s most serious classification. FDA assigns Class I when there is a reasonable probability that use of, or exposure to, the recalled product will cause serious adverse health consequences or death. This classification does not mean harm has already occurred in every case -- it reflects FDA’s assessment of the realistic worst-case risk profile of the defect described in the recall, based on the reason for recall reported by the firm. Class I recalls receive the closest FDA monitoring of the three classes: the recalling firm typically must submit a recall strategy, periodic status reports, and effectiveness checks confirming that the affected lots have actually been removed from distribution or corrected in the field.
What consumers should do
Facilities, clinicians, and consumers holding an affected unit or lot of Glutathione 200 mg/mL, 30 mL sterile multidose vial, Each vial contains: Glutathione, Ascorbic Acid, Benzyl Alcohol & sterile water for injection, For IM or IV Injection Use Only, RX only, Optimal Balance Pharmacy, 2204 Cypress Creek Pkwy Suite F, Houston, TX 77090 should stop using it for the purpose described in the recall notice and hold remaining stock pending instructions from OPTIMAL BALANCE PHARMACY. FDA recall records typically direct the recalling firm to notify known accounts directly with a recall letter describing the specific corrective action -- replacement, field correction, refund, or return. Anyone who received the product through a distributor rather than directly from OPTIMAL BALANCE PHARMACY should confirm with their supplier whether their specific lot or unit is on the affected list, since recall notices are lot- or unit-specific and not every unit of a product line is necessarily included. Questions about a specific unit's status should go to OPTIMAL BALANCE PHARMACY directly or to the distributor that supplied it; Argus HQ is a public-record aggregator, not the recalling firm, and cannot confirm individual unit status.
OPTIMAL BALANCE PHARMACY’s FDA history
Argus HQ has recorded 1 total FDA action tied to OPTIMAL BALANCE PHARMACY: 0 warning letters, 1 recall, 0 approval records, and 0 Form 483 inspection citations.
Frequently asked questions
- Is Glutathione 200 mg/mL, 30 mL sterile multidose vial, Each vi recalled?
- Yes. FDA lists a Class I recall by OPTIMAL BALANCE PHARMACY for Glutathione 200 mg/mL, 30 mL sterile multidose vial, Each vial contains: Glutathione, Ascorbic Acid, Benzyl Alcohol & sterile water for injection, For IM or IV Injection Use Only, RX only, Optimal Balance Pharmacy, 2204 Cypress Creek Pkwy Suite F, Houston, TX 77090, reported 20260909, with status "Ongoing." FDA recall number: D-0851-2026.
- What is the recall class for OPTIMAL BALANCE PHARMACY's recall?
- FDA classified this recall as Class I. A Class I recall is FDA’s most serious classification. FDA assigns Class I when there is a reasonable probability that use of, or exposure to, the recalled product will cause serious adverse health consequences or death.
- Why was Glutathione 200 mg/mL, 30 mL sterile multidose vial, Each vi recalled?
- FDA's recall record states the reason as: Microbial Contamination of Sterile Products - out of specifications results were obtained for bacterial endotoxin.
- Who should I contact about this recall?
- Contact OPTIMAL BALANCE PHARMACY directly, or the distributor/pharmacy that supplied the product, to confirm whether your specific lot or unit is affected. Argus HQ aggregates the public FDA recall record and is not the recalling firm.
Know if this happens again — we'll email you.
Free. No spam, just recall alerts for what you tell us to watch.
Related enforcement actions
Full FDA history for OPTIMAL BALANCE PHARMACYCompiled by Argus HQ Research from FDA primary sources · Reviewed by Andy Gaber, Founder
Cite this record
Reusing this data in reporting or research? Here’s a ready-made citation.
Argus HQ Research (2026). Recall Record: Class I Recall: Glutathione 200 mg/mL, 30 mL sterile multidose vial,… by OPTIMAL BALANCE PHARMACY. Digital Empire Holdings LLC. Retrieved from https://argushq.ai/recall/optimal-balance-pharmacy-d-0851-2026-2026-09-09
"Recall Record: Class I Recall: Glutathione 200 mg/mL, 30 mL sterile multidose vial,… by OPTIMAL BALANCE PHARMACY." Argus HQ Research, Digital Empire Holdings LLC, 2026, argushq.ai/recall/optimal-balance-pharmacy-d-0851-2026-2026-09-09.
Argus HQ Research. "Recall Record: Class I Recall: Glutathione 200 mg/mL, 30 mL sterile multidose vial,… by OPTIMAL BALANCE PHARMACY." Digital Empire Holdings LLC. Accessed September 23, 2026. https://argushq.ai/recall/optimal-balance-pharmacy-d-0851-2026-2026-09-09.
@misc{argushq_argushq_ai_recall_optimal_balance_pharmacy_d_0851_2026_2026_09_09_2026,
title = {Recall Record: Class I Recall: Glutathione 200 mg/mL, 30 mL sterile multidose vial,… by OPTIMAL BALANCE PHARMACY},
author = {{Argus HQ Research}},
year = {2026},
publisher = {Digital Empire Holdings LLC},
url = {https://argushq.ai/recall/optimal-balance-pharmacy-d-0851-2026-2026-09-09},
note = {Accessed: September 23, 2026}
}Source: FDA.gov — Recalls ↗

